51 Infants Hospitalized in Unprecedented Botulism Cluster (Image Credits: Pixabay)
The U.S. Food and Drug Administration outlined plans to intensify testing of dairy ingredients in infant formula for Clostridium botulinum spores next year, prompted by an outbreak that hospitalized 51 infants nationwide.[1][2]
51 Infants Hospitalized in Unprecedented Botulism Cluster
A surge in infant botulism cases beginning in August 2025 caught health officials off guard, marking the first documented U.S. outbreak tied to contaminated powdered infant formula.[1] All 51 affected infants required hospitalization, though none succumbed to the illness. Symptoms emerged within 30 days of exposure, including constipation, feeding difficulties, weak cries, and loss of head control.[2]
Cases spanned 19 states: Arizona, California, Idaho, Illinois, Kentucky, Massachusetts, Maine, Michigan, Minnesota, North Carolina, New Jersey, Ohio, Oregon, Pennsylvania, Rhode Island, Texas, Virginia, Washington, and Wisconsin.[1] The infants ranged from 16 to 264 days old, with 43% female. Epidemiological data pointed squarely to ByHeart Whole Nutrition Infant Formula, which represented just 1% of U.S. formula sales yet dominated among sick infants.[2]
Dairy Ingredient Emerges as Contamination Culprit
FDA laboratory analysis confirmed Clostridium botulinum type A spores in ByHeart formula samples, matching clinical isolates from affected infants through whole genome sequencing.[1] Investigators traced the source to organic whole milk powder, a key dairy component supplied to ByHeart and processed at a facility in Fallon, Nevada.[3]
ByHeart’s own tests detected the bacterium in six of 36 finished product samples from recalled batches. FDA collected additional samples from suppliers, including non-fat dry milk powder and whey protein concentrate. The agency noted the challenges of detection: heat-resistant spores demand specialized activation and equipment, often delaying results by weeks.[4] No other formula brands showed links to the outbreak.
Swift Recalls and Retailer Crackdown
ByHeart initiated a voluntary recall on November 8, 2025, starting with two contaminated lots before expanding to all products nationwide and internationally.[1] The recall covered cans and single-serve packs sold online and in stores, including major chains like Walmart and Target. FDA conducted over 4,300 audit checks and issued warning letters to four retailers for failing to fully remove products.[5]
Despite these efforts, reports surfaced of recalled formula lingering on shelves into December 2025. The agency reminded industry of obligations under the Federal Food, Drug, and Cosmetic Act. No new cases appeared after December 10, 2025, signaling the recall’s impact.[2]
Path Forward: Proactive Ingredient Surveillance
In response, FDA launched a targeted sampling assignment on dairy-based ingredients commonly used in formula production. Officials emphasized ongoing collaboration with CDC, states, and industry to refine testing protocols for faster, more reliable spore detection.[5] The agency also engaged international experts for risk assessments on spore-forming pathogens in powdered formula.
“While these results advance FDA’s understanding of the outbreak, FDA’s investigation is ongoing to determine the source of contamination,” the agency stated.[4] This incident prompted a broader review of manufacturing hazards, building on prior guidance to consider Clostridium botulinum risks. Parents received clear directives: discard any ByHeart products and consult physicians for symptoms.
Key Takeaways:
- 51 infants hospitalized across 19 states from ByHeart formula contaminated with botulism spores.
- Organic whole milk powder identified as source via FDA genome sequencing.
- FDA expands dairy ingredient testing to prevent future outbreaks.
This outbreak underscored vulnerabilities in infant nutrition supply chains, driving FDA toward stricter ingredient scrutiny. Enhanced testing next year promises greater safeguards for the most vulnerable. What steps should parents take to ensure formula safety? Share your thoughts in the comments.
